Johanna Mercier - 17 Aug 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Aug 2026, 18:54:04 UTC
Prior SEC filing
16 Jul 2026
Next SEC filing
11 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Amy Kim by Power of Attorney for Johanna Mercier

Key filing fact

Johanna Mercier filed Form 4 for GILEAD SCIENCES, INC. (GILD) on 18 Aug 2026.

Key facts

  • This page summarizes Johanna Mercier's Form 4 filing for GILEAD SCIENCES, INC. (GILD).
  • 6 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2026, 18:54.

Change

  • Previous filing in this sequence was filed on 16 Jul 2026.
  • Current net transaction value: -$3,853,908.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001782135 Primary reporting owner

Mercier Johanna

Relationship
Chief Comm & Corp Aff Officer
Address
GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE, FOSTER CITY
Signature
/s/ Amy Kim by Power of Attorney for Johanna Mercier
Signature date
18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GILD transaction

Common Stock

Options Exercise

Transaction value
Shares
+23,110
Change %
+19%
Price
$66.64*
Shares after
144,344
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Options Exercise

Transaction value
Shares
+1,890
Change %
+1.3%
Price
$72.34*
Shares after
146,234
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1
GILD transaction

Common Stock

Sale

Transaction value
$2,270,643
Shares
-16,530
Change %
-11%
Price
$137.36
Shares after
129,704
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1, F2
GILD transaction

Common Stock

Sale

Transaction value
$1,583,265
Shares
-11,470
Change %
-8.8%
Price
$138.04
Shares after
118,234
Date
17 Aug 2026
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-23,110
Change %
-100%
Price
$0.000000*
Shares after
0
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,110
Exercise price
$66.64
Footnotes
F1, F4
GILD transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-1,890
Change %
-2.6%
Price
$0.000000*
Shares after
69,960
Date
17 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,890
Exercise price
$72.34
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.

Footnote F2

Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F3

Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.

Footnote F4

The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .